发明名称 BICYCLIC HETEROCYCLIC COMPOUND
摘要 <p>[Problem] To provide a compound useful as an active ingredient of a pharmaceutical composition for treating 11²-hydroxysteroid dehydrogenase type 1-related diseases such as dementia, schizophrenia, depression, pain (particularly, neuropathic pain or fibromyalgia), diabetes (particularly, type II diabetes mellitus), insulin resistance and the like. [Means for Solution] A bicyclic heterocyclic compound (the bicyclic heterocycle is formed when a cyclohexane ring is fused with a 5- to 6-membered monocyclic heterocycle that has only a nitrogen atom as a hetero atom) substituted with an acylamino group such as a (hetero)aroylamino group or the like or a pharmaceutically acceptable salt thereof was found to have an excellent selective inhibitory action against 11²-HSD1. Accordingly, the bicyclic heterocyclic compound of the present invention can be used for treating dementia, schizophrenia, depression, pain (particularly, neuropathic pain or fibromyalgia), diabetes (particularly, type II diabetes mellitus), insulin resistance, and the like.</p>
申请公布号 KR20140081860(A) 申请公布日期 2014.07.01
申请号 KR20147012520 申请日期 2012.10.17
申请人 ASTELLAS PHARMA INC. 发明人 KAWAKAMI SHIMPEI;SAKURAI MINORU;KAWANO NORIYUKI;SUZUKI TAKAYUKI;SHIRAISHI NOBUYUKI;HAMAGUCHI WATARU;SEKIOKA RYUICHI;MORITOMO HIROYUKI;MORITOMO AYAKO
分类号 C07D231/56;A61K31/416;A61P25/00;C07D231/54 主分类号 C07D231/56
代理机构 代理人
主权项
地址